Bing Jia

3.4k total citations
108 papers, 2.7k citations indexed

About

Bing Jia is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology and Allergy. According to data from OpenAlex, Bing Jia has authored 108 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Radiology, Nuclear Medicine and Imaging, 39 papers in Oncology and 35 papers in Immunology and Allergy. Recurrent topics in Bing Jia's work include Radiopharmaceutical Chemistry and Applications (46 papers), Cell Adhesion Molecules Research (35 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Bing Jia is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (46 papers), Cell Adhesion Molecules Research (35 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Bing Jia collaborates with scholars based in China, United States and Ethiopia. Bing Jia's co-authors include Fan Wang, Zhaofei Liu, Jiyun Shi, Huiyun Zhao, Shuang Liu, Liquan Gao, Young‐Seung Kim, Chenran Zhang, Xiaohong Chen and Duo Gao and has published in prestigious journals such as ACS Nano, PLoS ONE and Biomaterials.

In The Last Decade

Bing Jia

105 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Jia China 30 1.2k 886 704 676 601 108 2.7k
Jiyun Shi China 32 1.3k 1.0× 880 1.0× 733 1.0× 727 1.1× 646 1.1× 95 2.9k
Johannes Notni Germany 32 1.6k 1.2× 929 1.0× 865 1.2× 265 0.4× 896 1.5× 83 3.2k
Zhaofei Liu China 40 1.8k 1.5× 1.4k 1.6× 1.6k 2.3× 1.4k 2.1× 944 1.6× 119 5.0k
Dorothy A. Sipkins United States 18 415 0.3× 803 0.9× 1.1k 1.6× 415 0.6× 246 0.4× 30 3.0k
Cathelijne Frielink Netherlands 21 736 0.6× 557 0.6× 545 0.8× 202 0.3× 332 0.6× 51 1.8k
Sanjiv S. Gambhir United States 17 760 0.6× 325 0.4× 529 0.8× 602 0.9× 410 0.7× 25 1.7k
Zhengming Xiong United States 16 574 0.5× 379 0.4× 536 0.8× 274 0.4× 349 0.6× 20 1.4k
Susanne Kossatz Germany 24 397 0.3× 760 0.9× 617 0.9× 475 0.7× 161 0.3× 63 1.8k
Gamal Akabani United States 29 1.9k 1.5× 669 0.8× 533 0.8× 227 0.3× 136 0.2× 67 3.1k
Jennifer R. Allport United States 20 384 0.3× 327 0.4× 835 1.2× 342 0.5× 485 0.8× 25 2.2k

Countries citing papers authored by Bing Jia

Since Specialization
Citations

This map shows the geographic impact of Bing Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Jia more than expected).

Fields of papers citing papers by Bing Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Jia. The network helps show where Bing Jia may publish in the future.

Co-authorship network of co-authors of Bing Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Jia. A scholar is included among the top collaborators of Bing Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Jia. Bing Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xin, Hui Chen, Fei Xie, et al.. (2025). Development and First-in-Human evaluation of a Site-Specific [18F]-Labeled PD-L1 nanobody PET radiotracer for noninvasive imaging in NSCLC. Bioorganic Chemistry. 156. 108222–108222. 4 indexed citations
3.
Qi, Changsong, Rui Guo, Yan Chen, et al.. (2024). 68Ga-NC-BCH Whole-Body PET Imaging Rapidly Targets Claudin18.2 in Lesions in Gastrointestinal Cancer Patients. Journal of Nuclear Medicine. 65(6). 856–863. 13 indexed citations
4.
Jia, Bing, et al.. (2023). Molecular coordination-doping engineering enables adjustable ion transport channel based on MOFs-derived UIOLiTF-LLZTO ionic conductor. Journal of Material Science and Technology. 163. 113–120. 3 indexed citations
5.
Li, Liqiang, Lin Wang, Ziqing Zeng, et al.. (2023). Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside. European Journal of Nuclear Medicine and Molecular Imaging. 50(12). 3735–3749. 19 indexed citations
6.
Jia, Bing, Zhemin Zhu, & Hang Gao. (2021). International Comparative Study of Statistics Learning Trajectories Based on PISA Data on Cognitive Diagnostic Models. Frontiers in Psychology. 12. 657858–657858. 5 indexed citations
7.
Zhao, Yang, Chenran Zhang, Liquan Gao, et al.. (2017). Chemotherapy-Induced Macrophage Infiltration into Tumors Enhances Nanographene-Based Photodynamic Therapy. Cancer Research. 77(21). 6021–6032. 21 indexed citations
8.
Li, Liqiang, Yue Wu, Zihua Wang, et al.. (2017). SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe 99mTc-HYNIC-H6F in Breast Cancer Mouse Models. Journal of Nuclear Medicine. 58(5). 821–826. 64 indexed citations
9.
Li, Yue, et al.. (2016). Catalytic Combustion of <i>n</i>-Hexanal Using Cu-Mn Composite Oxide Supported on TiO<sub>2</sub>. Acta Physico-Chimica Sinica. 32(8). 2084–2092. 8 indexed citations
10.
Gao, Liquan, Hao Liu, Xianlei Sun, et al.. (2015). Molecular Imaging of Post-Src Inhibition Tumor Signatures for Guiding Dasatinib Combination Therapy. Journal of Nuclear Medicine. 57(2). 321–326. 9 indexed citations
11.
Liu, Zhaofei, Xianlei Sun, Hao Liu, et al.. (2014). Early Assessment of Tumor Response to Gefitinib Treatment by Noninvasive Optical Imaging of Tumor Vascular Endothelial Growth Factor Expression in Animal Models. Journal of Nuclear Medicine. 55(5). 818–823. 19 indexed citations
12.
Zeng, Jianfeng, Bing Jia, Ruirui Qiao, et al.. (2014). In situ111In-doping for achieving biocompatible and non-leachable 111In-labeled Fe3O4 nanoparticles. Chemical Communications. 50(17). 2170–2170. 47 indexed citations
13.
Gao, Shi, et al.. (2013). 99mTc-3P4-RGD2 radiotracers for SPECT/CT of esophageal tumor. 《核技术》(英文版). 24(4). 40302–40302. 3 indexed citations
14.
Zhao, Huiyun, Bing Jia, Fan Wang, & Zhaofei Liu. (2013). Tumor targeting of 125I-labeled anti-EGFR monoclonal antibody LA22 in HT-29 human colon cancer. 《核技术》(英文版). 21(2).
15.
Gao, Shi, et al.. (2013). Pharmacokinetics and radiation dosimetry of ~(99m)Tc-3PRGD_2 in healthy individuals:A pilot study. Nuclear Science and Techniques. 23(6). 349–354. 4 indexed citations
16.
Cui, Liyang, Zhaofei Liu, Xiaona Jin, et al.. (2012). Evaluation of 188Re-MAG2-RGD-bombesin for potential prostate cancer therapy. Nuclear Medicine and Biology. 40(2). 182–189. 17 indexed citations
17.
Shi, Jiyun, Yang Zhou, Sudipta Chakraborty, et al.. (2011). Evaluation of 111In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability. Theranostics. 1. 322–340. 45 indexed citations
18.
Liu, Zhaofei, Yan Liu, Bing Jia, et al.. (2010). Epidermal Growth Factor Receptor–Targeted Radioimmunotherapy of Human Head and Neck Cancer Xenografts Using 90Y-Labeled Fully Human Antibody Panitumumab. Molecular Cancer Therapeutics. 9(8). 2297–2308. 26 indexed citations
19.
Jia, Bing, Zhaofei Liu, Zhaohui Zhu, et al.. (2010). Blood Clearance Kinetics, Biodistribution, and Radiation Dosimetry of a Kit-Formulated Integrin αvβ3-Selective Radiotracer 99mTc-3PRGD2 in Non-Human Primates. Molecular Imaging and Biology. 13(4). 730–736. 68 indexed citations
20.
Veeravagu, Anand, Zhaofei Liu, Gang Niu, et al.. (2008). Integrin αvβ3-Targeted Radioimmunotherapy of Glioblastoma Multiforme. Clinical Cancer Research. 14(22). 7330–7339. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026